New treatment study aims to help underrepresented patients breathe and smell better
NCT ID NCT05246267
Summary
This study is testing whether adding the medication dupilumab to standard nasal sprays improves symptoms and sense of smell in patients with chronic sinusitis and nasal polyps. It focuses on including more racial and ethnic minority patients, who are often underrepresented in research. Researchers will follow 60 participants for about a year to measure changes in their symptoms, smell ability, and breathing.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHRONIC RHINOSINUSITIS WITH NASAL POLYPS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Montefiore Medical Center
RECRUITINGThe Bronx, New York, 10461, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.